Board Meeting17 Apr 2026, 10:11 pm
Astec Lifesciences Board to consider FY26 results on April 27, 2026
AI Summary
Astec Lifesciences Ltd has announced that its Board of Directors will convene a meeting on Monday, April 27, 2026. The primary agenda for this meeting is to consider and approve the Standalone and Consolidated Audited Financial Results and Statements for the Quarter and Financial Year ended March 31, 2026. These results will be reviewed by the Audit Committee prior to Board approval, in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for April 27, 2026.
- Purpose is to consider and approve Q4 and FY26 audited financial results.
- Standalone and Consolidated results will be reviewed by Audit Committee.
- Announcement made as per SEBI Listing Regulations.